Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Significance: Rho-associated kinase 2 (ROCK2) is implicated in the regulation of proinflammatory cytokines, such as IL-17 and IL-21, and the development of autoimmunity in mice. However, the role of ROCK2 signaling pathway in regulation of immune responses in humans is still an enigma. Here we show that targeted ROCK2 inhibition down-regulates proinflammatory responses via concurrent regulation of STAT3/STAT5 phosphorylation and shifting Th17/Treg balance in human T cells with a minimal effect on the rest of the immune response. This work provides previously unidentified insights into the molecular mechanism of ROCK2-mediated modulation of the immune response in man and has profound implications for development of a selective ROCK2 inhibitor as a new therapeutic target for autoimmunity treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Next-generation, highly selective ROCK2 inhibitors such as KD025 have demonstrated the ability to modulate STAT3 signaling,correct immune dysregulation, and suppress immune-mediated fibrotic progression (139-141).”
From The mechanotransduction-immune axis in organ fibrosis: dual regulatory mechanisms and translational therapeutic perspectives (2025) · doi:10.3389/fimmu.2025.1670213 · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 1×
“Indeed, the differential activity of STAT3 and STAT5 in Th17 cells and Tregs may act via their opposing effects on Foxp3 expression (26).”
BackgroundPrevoo, M. L. L., Van'T Hof, M. A., Kuper, H. H., Van Leeuwen, M. A., Van De Putte, L. B. A., & Van Riel, P. L. C. M. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380107 · Cited by 6,243
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 4,992
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873 · cited 1×
“The generation of Th17 cells is induced by a combination of several cytokines including transforming growth factor-β (TGF-β1), IL-1β, IL-6, and IL-23, and involves the activation of transcription factors, such as RAR-related orphan receptor (ROR) γt, RORα, IFN regulatory factor (IRF) 4, and signal transducer and activ…”
BackgroundZhou, L., Ivanov, I. I., Spolski, R., Min, R., Shenderov, K., Egawa, T., Levy, D. E., Leonard, W. J., & Littman, D. R. (2007) · Nature Immunology · doi:10.1038/ni1488 · Cited by 2,141
ROCKs: multifunctional kinases in cell behaviour
Riento, K., & Ridley, A. J. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1128 · Cited by 1,941 · cited 2×
“Thus, although ROCK proteins are involved in cytoskeleton organization (9), signaling via other Rho GTPases, such as Cdc42, is sufficient to mediate the cytoskeleton rearrangement that is required for IS formation (21).”
BackgroundPlasticity of CD4+ T Cell Lineage Differentiation
Zhou, L., Chong, M. M. W., & Littman, D. R. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.001 · Cited by 1,551 · cited 1×
“It has been shown that TGF-β is critical for the development and function of both Th17 cells and regulatory forkhead box p3 (Foxp3) T cells (Tregs), suggesting an intimate link between the differentiation programs of these two T-cell subsets (25).”
BackgroundManel, N., Unutmaz, D., & Littman, D. R. (2008) · Nature Immunology · doi:10.1038/ni.1610 · Cited by 1,291
Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling
Chung, Y., Chang, S. H., Martinez, G. J., Yang, X. O., Nurieva, R., Kang, H. S., Ma, L., Watowich, S. S., Jetten, A. M., Tian, Q., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.02.007 · Cited by 1,199 · cited 1×
“Both IL-21 and IL-17 are primarily produced by the subset of CD4 T cells recently defined as Th17 cells; KD025 was tested on cytokine secretion under Th17-skewing activation, which requires the presence of IL-1β and TGF-β during TCR stimulation (22, 23).”
BackgroundTH17 cells in development: an updated view of their molecular identity and genetic programming
Dong, C. (2008) · Nature reviews. Immunology · doi:10.1038/nri2295 · Cited by 1,064 · cited 1×
“CD4 T cells are a major source of IL-21 and IL-17 (17, 18).”
BackgroundHuman interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium
Chabaud, M., Durand, J. M., Buchs, N., Fossiez, F., Page, G., Frappart, L., & Miossec, P. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199905)42:5<963::aid-anr15>3.0.co;2-e · Cited by 954 · cited 2×
“The IL-17 is produced spontaneously by RA synovial cultures, and IL-17–producing cells were found in T-cell–rich areas (5).”
BackgroundVarma, R., Campi, G., Yokosuka, T., Saito, T., & Dustin, M. L. (2006) · Immunity · doi:10.1016/j.immuni.2006.04.010 · Cited by 879
Self-citationInterleukin-21: Basic Biology and Implications for Cancer and Autoimmunity
Spolski, R., & Leonard, W. J. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090316 · Cited by 696 · cited 1×
“CD4 T cells are a major source of IL-21 and IL-17 (17, 18).”
BackgroundThe development of inflammatory TH-17 cells requires interferon-regulatory factor 4
Brüstle, A., Heink, S., Huber, M., Rosenplänter, C., Stadelmann, C., Yu, P., Arpaia, E., Mak, T. W., Kamradt, T., & Lohoff, M. (2007) · Nature Immunology · doi:10.1038/ni1500 · Cited by 692 · cited 7×
“In conclusion, our data demonstrate the role of ROCK2 in controlling IL-21 and IL-17 secretion in human T cells via a mechanism that involves regulation through STAT3, IRF4, and RORγt.”
BackgroundInfluentialDevelopment of anti-TNF therapy for rheumatoid arthritis
Feldmann, M. (2002) · Nature Reviews Immunology · doi:10.1038/nri802 · Cited by 673 · cited 1×
“RA is a chronic autoimmune disorder characterized by extensive joint inflammation that leads to significant tissue damage (28).”
BackgroundNie, H., Zheng, Y., Li, R., Guo, T. B., He, D., Fang, L., Liu, X., Xiao, L., Chen, X., Wan, B., et al. (2013) · Nature Medicine · doi:10.1038/nm.3085 · Cited by 515 · cited 1×
“In addition, Treg-suppressive activity has been previously shown to be diminished in RA patients (20, 38) and may contribute to excessive IFN-γ levels observed in these patients (Fig.”
BackgroundTranscriptional regulation of Th17 cell differentiation
Ivanov, I. I., Zhou, L., & Littman, D. R. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.011 · Cited by 484 · cited 9×
“The generation of Th17 cells is induced by a combination of several cytokines including transforming growth factor-β (TGF-β1), IL-1β, IL-6, and IL-23, and involves the activation of transcription factors, such as RAR-related orphan receptor (ROR) γt, RORα, IFN regulatory factor (IRF) 4, and signal transducer and activ…”
BackgroundInfluentialFunctional Anatomy of T Cell Activation and Synapse Formation
Fooksman, D. R., Vardhana, S., Vasiliver-Shamis, G., Liese, J., Blair, D. A., Waite, J., Sacristán, C., Victora, G. D., Zanin-Zhorov, A., & Dustin, M. L. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101308 · Cited by 446 · cited 1×
“S4 A and B) and are recruited to the immunological synapse (IS), a structured interface between antigen-presenting cells and T cells (19) (Fig.”
BackgroundSelf-citationEdlund, S., Landström, M., Heldin, C.-H., & Aspenström, P. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-08-0398 · Cited by 418
ROCK and JAK1 Signaling Cooperate to Control Actomyosin Contractility in Tumor Cells and Stroma
Sanz-Moreno, V., Gaggioli, C., Yeo, M., Albrengues, J., Wallberg, F., Viros, A., Hooper, S., Mitter, R., Féral, C. C., Cook, M., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.018 · Cited by 409 · cited 1×
“Because ROCK is a serine/threonine kinase and cannot directly mediate STAT3 phosphorylation on Tyr-705, it is likely that tyrosine kinases such JAK and Src or other intracellular signaling components, which may interface between ROCK and STAT3, are also engaged in this ROCK-dependent activation of STAT3 (36).”
BackgroundApplications for ROCK kinase inhibition
Olson, M. F. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.01.002 · Cited by 347 · cited 1×
“The two ROCK isoforms (ROCK1 and ROCK2) appear to be interesting potential targets for the treatment of a wide range of pathological conditions including cancer, neuronal degeneration, and cardiovascular diseases (37).”
BackgroundProtein Kinase C-θ Mediates Negative Feedback on Regulatory T Cell Function
Zanin-Zhorov, A., Ding, Y., Kumari, S., Attur, M., Hippen, K. L., Brown, M., Blazar, B. R., Abramson, S. B., Lafaille, J. J., & Dustin, M. L. (2010) · Science · doi:10.1126/science.1186068 · Cited by 289
Self-citationSignal transduction pathways and transcriptional regulation in the control of Th17 differentiation
Chen, Z., Laurence, A., & O'Shea, J. J. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.015 · Cited by 274 · cited 9×
“The generation of Th17 cells is induced by a combination of several cytokines including transforming growth factor-β (TGF-β1), IL-1β, IL-6, and IL-23, and involves the activation of transcription factors, such as RAR-related orphan receptor (ROR) γt, RORα, IFN regulatory factor (IRF) 4, and signal transducer and activ…”
BackgroundInfluentialRho family GTPases and their regulators in lymphocytes
Tybulewicz, V. L. J., & Henderson, R. B. (2009) · Nature Reviews Immunology · doi:10.1038/nri2606 · Cited by 272 · cited 1×
“Rho GTPase-mediated signaling pathways play a central role in the coordination and balancing of T-cell–mediated immune responses, including T-cell receptor (TCR)-mediated signaling, cytoskeletal reorganization, and the acquisition of the appropriate T-cell effector program (8).”
BackgroundBiswas, P. S., Gupta, S., Chang, E., Song, L., Stirzaker, R. A., Liao, J. K., Bhagat, G., & Pernis, A. B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42856 · Cited by 236 · cited 2×
“Recent studies have demonstrated that ROCK2 regulates the production of both IL-21 and IL-17 and plays an essential role in the development of autoimmunity in mice (10, 11).”
BackgroundRegulation of STAT3 by Direct Binding to the Rac1 GTPase
Simon, A. R., Vikis, H. G., Stewart, S., Fanburg, B. L., Cochran, B. H., & Guan, K.-L. (2000) · Science · doi:10.1126/science.290.5489.144 · Cited by 224 · cited 1×
“Indeed, it has been shown that activated Rac1 can directly bind to and activate STAT3 (32) or indirectly activate STAT3 through the induction of IL-6 (33) and that active RhoA, but not Rac1, can stimulate STAT3-responsive gene induction (34).”
BackgroundLubberts, E. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-009-0189-9 · Cited by 173 · cited 1×
“Both IL-21 and IL-17 are involved in pathogenesis of RA (5, 29).”
BackgroundHow does the immune system distinguish self from nonself?
Medzhitov, R., & Janeway Jr, C. A. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0230 · Cited by 161 · cited 2×
“the pathogenesis of inflammatory arthritis? Immunol Rev 233(1):79–96.”
BackgroundRac1 mediates STAT3 activation by autocrine IL-6
Faruqi, T. R., Gomez, D., Bustelo, X. R., Bar-Sagi, D., & Reich, N. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161281298 · Cited by 147 · cited 4×
“Zhou L, et al. (2007) IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways.”
BackgroundInfluentialA Role of STAT3 in Rho GTPase-regulated Cell Migration and Proliferation
Debidda, M., Wang, L., Zang, H., Poli, V., & Zheng, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413187200 · Cited by 145 · cited 1×
“Notably, activation of ROCK pathways can partially activate STAT3, and through the participation of other effectors, such as mDia, ROCK activity is required to fully promote the RhoA-mediated STAT3 activation (35).”
BackgroundSelective ROCK 2 inhibition in focal cerebral ischemia
Hyun Lee, J., Zheng, Y., Bornstadt, D., Wei, Y., Balcioglu, A., Daneshmand, A., Yalcin, N., Yu, E., Herisson, F., Atalay, Y. B., et al. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.19 · Cited by 123 · cited 5×
“KD025 is ATP competitive and 100-fold more selective for the ROCK2 over ROCK1 isoform (16).”
BackgroundMethodSelf-citationHe, Y., Xu, H., Liang, L., Zhan, Z., Yang, X., Yu, X., Ye, Y., & Sun, L. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23986 · Cited by 112 · cited 3×
“These findings suggest that an increase in disease severity leads to up-regulation of the ROCK2-dependent component of IFN-γ secretion, consistent with previously reported elevated ROCK activity in RA (13).”
BackgroundResultChemin, K., Bohineust, A., Dogniaux, S., Tourret, M., Guégan, S., Miro, F., & Hivroz, C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200156 · Cited by 104 · cited 1×
“Thus, although ROCK proteins are involved in cytoskeleton organization (9), signaling via other Rho GTPases, such as Cdc42, is sufficient to mediate the cytoskeleton rearrangement that is required for IS formation (21).”
BackgroundAznar, S., Valerón, P. F., del Rincon, S. V., Pérez, L. F., Perona, R., & Lacal, J. C. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.10.3282 · Cited by 103 · cited 1×
“Indeed, it has been shown that activated Rac1 can directly bind to and activate STAT3 (32) or indirectly activate STAT3 through the induction of IL-6 (33) and that active RhoA, but not Rac1, can stimulate STAT3-responsive gene induction (34).”
BackgroundBoerma, M., Fu, Q., Wang, J., Loose, D. S., Bartolozzi, A., Ellis, J. L., McGonigle, S., Paradise, E., Sweetnam, P., Fink, L. M., et al. (2008) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e32830b2891 · Cited by 100 · cited 3×
“We designed this randomized (6:2), double-blind, placebo-controlled, dose-escalating study to evaluate the safety, tolerability, pharmacokinetics (PK), and exploratory pharmacodynamics (PD) of single and seven multiple doses of KD025 (formerly called Slx-2119) (15) in healthy male subjects between the ages of 18 and 5…”
BackgroundMethodHuman Th17 cells in infection and autoimmunity
Sallusto, F., & Lanzavecchia, A. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.04.004 · Cited by 94
Optimization of current and future therapy for autoimmune diseases
Steinman, L., Merrill, J. T., McInnes, I. B., & Peakman, M. (2012) · Nature Medicine · doi:10.1038/nm.2625 · Cited by 84 · cited 1×
“The approach is to develop therapies that target specific signaling pathways governing immune cell fate and activity rather than general immunosuppression (30).”
BackgroundIRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis?
Biswas, P. S., Bhagat, G., & Pernis, A. B. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00864.x · Cited by 81 · cited 1×
“Recent studies have demonstrated that ROCK2 regulates the production of both IL-21 and IL-17 and plays an essential role in the development of autoimmunity in mice (10, 11).”
BackgroundSun, X., Minohara, M., Kikuchi, H., Ishizu, T., Tanaka, M., Piao, H. Z., Osoegawa, M., Ohyagi, Y., Shimokawa, H., & Kira, J. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.06.027 · Cited by 80 · cited 1×
“Indeed, pan ROCK inhibition was reported to effectively down-regulate ongoing autoimmune response in animal models (11, 12).”
BackgroundEnhanced Rho‐Associated Protein Kinase Activation in Patients With Systemic Lupus Erythematosus
Isgro, J., Gupta, S., Jacek, E., Pavri, T., Duculan, R., Kim, M., Kirou, K. A., Salmon, J. E., & Pernis, A. B. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37934 · Cited by 68 · cited 2×
“Additionally, ROCK activity was found to be up-regulated in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) (13, 14), when the production of both IL-21 and IL-17 is deregulated, but to date there is no evidence of selective ROCK2 involvement in the regulation of proinflammatory cytokines…”
BackgroundTargeting interleukin-21 in inflammatory diseases
Sarra, M., Franzè, E., Pallone, F., & Monteleone, G. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.561319 · Cited by 27
Cited by
Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential
Feng, Y., LoGrasso, P. V., Defert, O., & Li, R. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00683 · Cited by 378
Cutler, C., Lee, S. J., Arai, S., Rotta, M., Zoghi, B., Lazaryan, A., Ramakrishnan, A., DeFilipp, Z., Salhotra, A., Chai-Ho, W., et al. (2021) · Blood · doi:10.1182/blood.2021012021 · Cited by 354
Self-citationNew Treatment Addressing the Pathogenesis of Psoriasis
Tokuyama, M., & Mabuchi, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207488 · Cited by 291
“KD025 is adenosine triphosphate (ATP) competitive and 100-fold more selective for the ROCK2 isoform when compared with ROCK1, with no significant activity against 300 other intracellular kinases and surface receptors [111,112].”
BackgroundInfluentialThe therapy of idiopathic pulmonary fibrosis: what is next?
Somogyi, V., Chaudhuri, N., Torrisi, S. E., Kahn, N., Müller, V., & Kreuter, M. (2019) · European Respiratory Review · doi:10.1183/16000617.0021-2019 · Cited by 265
Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders.
Fasching, P., Stradner, M., Graninger, W., Dejaco, C., & Fessler, J. (2017) · Molecules · doi:10.3390/molecules22010134 · Cited by 254
“Overall, KD025 induced a beneficial shift in the Th17/Treg balance [190].”
Background
Metadata
- Authors
- Zanin-Zhorov, A., Weiss, J. M., Nyuydzefe, M. S., Chen, W., Scher, J. U., Mo, R., Depoil, D., Rao, N., Liu, B., Wei, J., Lucas, S., Koslow, M., Roche, M., Schueller, O., Weiss, S., Poyurovsky, M. V., Tonra, J., Hippen, K. L., Dustin, M. L., Blazar, B. R., Liu, C.-J., & Waksal, S. D.
- Affiliations
- Kadmon Research Institute, New York, NY 10016;
- Kadmon Corporation (United States) (US)
- Division of Rheumatology and
- New York University (US)
- New York University Langone Orthopedic Hospital (US)
- Nano Terra (United States) (US)
- University of Minnesota (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2014-11-10
- Volume
- 111
- Issue
- 47
- Pages
- 16814-16819
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4250132
- OpenAlex
- W1997623655
- Cited by
- 262
- References
- 41
- Citations by year
- 2026: 28 · 2025: 27 · 2024: 26 · 2023: 31 · 2022: 19 · 2021: 31 · 2020: 22 · 2019: 14 · 2018: 18 · 2017: 19 · 2016: 16 · 2015: 9 · 2014: 1
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (100262, 100262/Z/12/Z)
- National Heart, Lung, and Blood Institute (R01HL056067, R01HL11879, R01HL118979)
- National Cancer Institute (P01CA142106, P01CA065493)
- National Institute of Allergy and Infectious Diseases (R01AI034495, P01AI056299)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K23AR064318)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- ROCK2, IL-21, IL-17, STAT3 phosphorylation, T cells, regulatory T cells, Th17 cells, collagen-induced arthritis, rheumatoid arthritis, autoimmunity, STAT5, Foxp3, oral administration, T cell receptor stimulation
- MeSH terms
- Interleukin-21, Administration, Oral, Cells, Cultured, Humans, Interleukins, Phosphorylation, Promoter Regions, Genetic, Transcription, Genetic, CD4-Positive T-Lymphocytes, Interleukin-17, Protein Kinase Inhibitors, STAT3 Transcription Factor, rho-Associated Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.